Press Releases
Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a Memorandum of Understanding (MoU) with the government of Canada to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Canada including access to Moderna’s...
Clinical Trials
AzurRx BioPharma Adds New Clinical Trial Sites in Ukraine for Phase 2 RESERVOIR of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
AzurRx BioPharma, Inc., a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, announced the completion of site initiation visits and the addition of five (5) new clinical trial sites in Ukraine for the...
Press Releases
Metrics Contract Services Unveils New Commercial Production Suites and Equipment
Metrics Contract Services (Metrics), a full-service global contract development and manufacturing organization (CDMO), has expanded its novel oral solid dose commercial facility in Greenville, North Carolina, adding 3,760 square feet of production space and new equipment.
The expansion completes a...
Press Releases
Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets
Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company and Canadian biotech firm SaNOtize Research & Development Corp. announced an exclusive long term strategic partnership to manufacture, market and distribute its breakthrough Nitric Oxide Nasal Spray (NONS) for COVID-19 treatment...
Press Releases
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine (mRNA-1345)
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the U.S. FDA as granted Fast Track designation for mRNA-1345, its investigational single-dose mRNA vaccine against respiratory syncytial virus (RSV) in adults older than 60...
Press Releases
DisperSol and Catalent Collaborate to Establish KinetiSol Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline
DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Press Releases
Ashfield Health Launches Health Intelligence Platform, GRAVITYai
Ashfield Health, a global healthcare marketing and communications network and part of UDG Healthcare, has launched Gravity.ai, a global healthcare intelligence data platform. The data solution is designed to support pharma, life science, biotech, and other healthcare partners to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















